WO1997007136B1 - Composition pharmaceutique contenant des inhibiteurs de l'inteferon gamma - Google Patents

Composition pharmaceutique contenant des inhibiteurs de l'inteferon gamma

Info

Publication number
WO1997007136B1
WO1997007136B1 PCT/GB1996/001949 GB9601949W WO9707136B1 WO 1997007136 B1 WO1997007136 B1 WO 1997007136B1 GB 9601949 W GB9601949 W GB 9601949W WO 9707136 B1 WO9707136 B1 WO 9707136B1
Authority
WO
WIPO (PCT)
Prior art keywords
ifn
inhibitor
healing
promoting
conjunction
Prior art date
Application number
PCT/GB1996/001949
Other languages
English (en)
Other versions
WO1997007136A2 (fr
WO1997007136A3 (fr
Filing date
Publication date
Priority claimed from GB9516967A external-priority patent/GB2304342A/en
Priority to AU67071/96A priority Critical patent/AU713809B2/en
Priority to JP50902597A priority patent/JP4070809B2/ja
Priority to AT96927141T priority patent/ATE208402T1/de
Priority to EP96927141A priority patent/EP0845007B1/fr
Priority to CA2229590A priority patent/CA2229590C/fr
Application filed filed Critical
Priority to DK96927141T priority patent/DK0845007T3/da
Priority to DE69616803T priority patent/DE69616803T2/de
Publication of WO1997007136A2 publication Critical patent/WO1997007136A2/fr
Publication of WO1997007136A3 publication Critical patent/WO1997007136A3/fr
Publication of WO1997007136B1 publication Critical patent/WO1997007136B1/fr
Priority to US11/014,209 priority patent/US7220413B2/en
Priority to US11/822,428 priority patent/US7727520B2/en

Links

Abstract

L'invention concerne des compositions et des méthodes pour favoriser la guérison des plaies ou des pathologies fibreuses en diminuant les cicatrices, comprenant des inhibiteurs de l'interféron η et son inhibition, ainsi que des compositions et des méthodes pour favoriser la guérison de plaies chroniques, comprenant des stimulants de l'interféron η et sa stimulation.
PCT/GB1996/001949 1995-08-18 1996-08-09 Composition pharmaceutique contenant des inhibiteurs de l'inteferon gamma WO1997007136A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE69616803T DE69616803T2 (de) 1995-08-18 1996-08-09 Pharmazeutische zusammensetzung enthaltend interferon-gamma inhibitoren
JP50902597A JP4070809B2 (ja) 1995-08-18 1996-08-09 インターフェロン−ガンマインヒビター含有医薬組成物
AT96927141T ATE208402T1 (de) 1995-08-18 1996-08-09 Pharmazeutische zusammensetzung enthaltend interferon-gamma inhibitoren
EP96927141A EP0845007B1 (fr) 1995-08-18 1996-08-09 Composition pharmaceutique contenant des inhibiteurs de l'inteferon gamma
CA2229590A CA2229590C (fr) 1995-08-18 1996-08-09 Composition pharmaceutique contenant des inhibiteurs de l'interferon- gamma
AU67071/96A AU713809B2 (en) 1995-08-18 1996-08-09 Pharmaceutical composition containing inhibitors of interferon- gamma
DK96927141T DK0845007T3 (da) 1995-08-18 1996-08-09 Farmaceutisk præparat indeholdende interferon-gamma hæmmere
US11/014,209 US7220413B2 (en) 1995-08-18 2004-12-17 Pharmaceutical composition containing inhibitors of interferon-γ
US11/822,428 US7727520B2 (en) 1995-08-18 2007-07-05 Method of promoting the healing of a chronic wound

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9516967.8 1995-08-18
GB9516967A GB2304342A (en) 1995-08-18 1995-08-18 Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US09029098 A-371-Of-International 1996-08-09
US45997999A Division 1995-08-18 1999-12-14
US09/790,898 Continuation US20020025316A1 (en) 1995-08-18 2001-02-23 Pharmaceutical composition containing inhibitors of interferon-gamma

Publications (3)

Publication Number Publication Date
WO1997007136A2 WO1997007136A2 (fr) 1997-02-27
WO1997007136A3 WO1997007136A3 (fr) 1997-08-21
WO1997007136B1 true WO1997007136B1 (fr) 1997-09-18

Family

ID=10779448

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1996/001949 WO1997007136A2 (fr) 1995-08-18 1996-08-09 Composition pharmaceutique contenant des inhibiteurs de l'inteferon gamma

Country Status (13)

Country Link
EP (2) EP0972521B1 (fr)
JP (2) JP4070809B2 (fr)
AT (2) ATE231728T1 (fr)
AU (1) AU713809B2 (fr)
CA (1) CA2229590C (fr)
DE (2) DE69616803T2 (fr)
DK (2) DK0972521T3 (fr)
ES (2) ES2192018T3 (fr)
GB (1) GB2304342A (fr)
HK (1) HK1023516A1 (fr)
PT (2) PT845007E (fr)
WO (1) WO1997007136A2 (fr)
ZA (1) ZA966953B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
CA2353520C (fr) 1998-12-09 2006-04-25 Protein Design Labs, Inc. Modele animal du psoriasis destine a la prevention et au traitement du psoriasis humain
US6710025B1 (en) 1999-05-26 2004-03-23 The Brigham And Women's Hospital, Inc. Treatment of damaged tissue using agents that modulate the activity of alpha-smooth muscle actin
CA2374301A1 (fr) * 1999-05-26 2000-11-30 Brigham And Women's Hospital, Inc. Utilisations therapeutiques d'agents modulant l'activite de l'actine alpha de muscle lisse
US10080779B2 (en) 2004-12-15 2018-09-25 Universite D'angers Method for increasing the expression of anti-microbial peptides by keratinocytes comprising administering a composition comprising IL-17, TNF-alpha and OSM
WO2008099829A1 (fr) * 2007-02-14 2008-08-21 Japan Science And Technology Agency Procédé de formation d'adhésion intestinale chez un animal expérimental, procédé de production d'animal expérimental présentant une adhésion intestinale, procédé de criblage d'agent de prévention d'adhérence intestinale, et agent de p
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
RU2539383C1 (ru) * 2013-11-29 2015-01-20 Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") Фармацевтическая композиция для лечения трофических язв и длительно незаживающих ран различной этиологии в виде мази

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78444A (en) * 1986-04-08 1992-05-25 Yeda Res & Dev Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody
JPH01502980A (ja) * 1986-06-17 1989-10-12 レイチ，スティーブン　デー ガンマインターフェロンと抗炎症剤または抗発熱剤との組合せ並びに疾患処置方法
NL8700927A (nl) * 1987-04-16 1988-11-16 Stichting Rega V Z W Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing.
CA1335792C (fr) * 1987-08-18 1995-06-06 Chaim O. Jacob Methode et forme posologique utilisant un antagoniste de l'interferon gamma pour lutter contre les maladies auto-immunes associees au cmh
AU2855189A (en) * 1988-01-25 1989-07-27 Baker Cummins Dermatologicals, Inc. Method of treating fibrotic disorders
IL88378A (en) * 1988-11-14 2000-11-21 Yeda Res & Dev Human interferon-gamma binding proteins their manufacture and pharmaceutical compositions comprising them
EP0374510B1 (fr) * 1988-12-19 1997-01-15 American Cyanamid Company Produits pour le traitement de choc endotoxique chez les mammifères
GB8905400D0 (en) * 1989-03-09 1989-04-19 Jonker Margreet Medicaments
DE69024398T2 (de) * 1989-04-19 1996-06-13 Hoffmann La Roche Auflösbare Interferon-gamma-Rezeptoren sowie Verfahren zu deren Herstellung
IT1231727B (it) * 1989-08-11 1991-12-21 Enrico Savoldi Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone.
IL91562A0 (en) * 1989-09-07 1990-04-29 Yeda Res & Dev Interferon-gamma receptor fragment and its production
DE69115917T2 (de) * 1990-09-27 1996-05-23 Schering Corp Humane gammainterferonantagonisten
EP0526630A4 (en) * 1991-02-22 1993-08-11 Amgen Inc. Use of gm-csf and g-csf to promote accelerated wound healing
NL9101290A (nl) * 1991-07-23 1993-02-16 Stichting Rega V Z W Recombinant dna-molecuul voor de expressie van een fv-fragment van een antilichaam.
DE4234380A1 (de) * 1992-10-06 1994-04-07 Schering Ag Verwendung von Dopaminagonisten zur Aktivierung des gamma-Interferon-Produktion
AU5669694A (en) * 1992-11-20 1994-06-22 Schering Corporation Antagonists of human gamma interferon
ATE173630T1 (de) * 1992-12-29 1998-12-15 Genentech Inc Behandlung von entzündlichen darmerkrankungen mit interferon-gamma-inhibitoren
EP0733111A1 (fr) * 1993-12-09 1996-09-25 Michel Aguet CHAINE $g(b) DE RECEPTEURS D'IFN-$g(g) ET LEURS DERIVES

Similar Documents

Publication Publication Date Title
HK1022440A1 (en) Combination therapy using a tnf binding protein for treating tnf-mediated diseases
WO2003037271A3 (fr) Composes, compositions pharmaceutiques et methodes d'utilisation
WO2000018419A3 (fr) Methodes d'administration d'antibiotiques
AU2275397A (en) Troponin subunits and fragments useful as angiogenesis inhibitors
EP0972517A3 (fr) Utilisations d'oxides de 1,2,4-benzotriazines pour la préparation d' un médicament pour le traitement de tumeurs
WO2001049275A3 (fr) Procedes et dispositifs destines a reduire la douleur
AU2147992A (en) Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
WO1997007136B1 (fr) Composition pharmaceutique contenant des inhibiteurs de l'inteferon gamma
WO1992019617A3 (fr) Composes de dibenzoxazepine substituee, compositions pharmaceutiques et procedes d'utilisation
AU6244898A (en) (d)-methadone, a nonopioid analgesic
AU9624198A (en) Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity
CA2229590A1 (fr) Composition pharmaceutique contenant des inhibiteurs de l'interferon- gamma
WO2002049575A3 (fr) Methode et composition pour le traitement de neuropathies diabetiques
MX9701820A (es) Compuestos de pirazolo [3,4-g] quinoxalina que inhiben proteina tirosina quinasa receptora de pdgf.
AU2002227052A1 (en) Treatments for neurogenetic disorders, impulse control disorders, and wound healing
US7220413B2 (en) Pharmaceutical composition containing inhibitors of interferon-γ
CA2235412A1 (fr) Composition pharmaceutique
WO2002064214A8 (fr) Methode de therapie anticancereuse
CA2154455A1 (fr) Composition analgesique
IL126175A (en) Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists
WO2003026564A3 (fr) Composition pharmaceutique
WO1998020835A3 (fr) Methode pour traiter l'hyperlipidemie chez l'homme
US20080031879A1 (en) Pharmaceutical composition containing inhibitors of interferon-gamma
WO1995005364A3 (fr) Inhibiteurs des transporteurs d'amine biogenes
WO2003080095B1 (fr) Activite dirigee contre l'ulcere gastro-duodenal d'une fleur de la plante woodfordia fructicosa